KYMR
Price
$81.32
Change
-$1.81 (-2.18%)
Updated
Dec 26 closing price
Capitalization
6.51B
53 days until earnings call
Intraday BUY SELL Signals
TBPH
Price
$18.84
Change
+$0.11 (+0.59%)
Updated
Dec 26 closing price
Capitalization
954.67M
64 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

KYMR vs TBPH

Header iconKYMR vs TBPH Comparison
Open Charts KYMR vs TBPHBanner chart's image
Kymera Therapeutics
Price$81.32
Change-$1.81 (-2.18%)
Volume$418.61K
Capitalization6.51B
Theravance Biopharma
Price$18.84
Change+$0.11 (+0.59%)
Volume$211.02K
Capitalization954.67M
KYMR vs TBPH Comparison Chart in %
View a ticker or compare two or three
VS
KYMR vs. TBPH commentary
Dec 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYMR is a Buy and TBPH is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 28, 2025
Stock price -- (KYMR: $81.32 vs. TBPH: $18.84)
Brand notoriety: KYMR and TBPH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYMR: 41% vs. TBPH: 41%
Market capitalization -- KYMR: $6.51B vs. TBPH: $954.67M
KYMR [@Biotechnology] is valued at $6.51B. TBPH’s [@Biotechnology] market capitalization is $954.67M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYMR’s FA Score shows that 0 FA rating(s) are green whileTBPH’s FA Score has 0 green FA rating(s).

  • KYMR’s FA Score: 0 green, 5 red.
  • TBPH’s FA Score: 0 green, 5 red.
According to our system of comparison, TBPH is a better buy in the long-term than KYMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYMR’s TA Score shows that 2 TA indicator(s) are bullish while TBPH’s TA Score has 3 bullish TA indicator(s).

  • KYMR’s TA Score: 2 bullish, 6 bearish.
  • TBPH’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, TBPH is a better buy in the short-term than KYMR.

Price Growth

KYMR (@Biotechnology) experienced а -3.18% price change this week, while TBPH (@Biotechnology) price change was +0.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.36%. For the same industry, the average monthly price growth was +0.27%, and the average quarterly price growth was +54.56%.

Reported Earning Dates

KYMR is expected to report earnings on Feb 19, 2026.

TBPH is expected to report earnings on Mar 02, 2026.

Industries' Descriptions

@Biotechnology (+0.36% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($6.51B) has a higher market cap than TBPH($955M). KYMR (102.138) and TBPH (100.213) have similar YTD gains . TBPH has higher annual earnings (EBITDA): 53.1M vs. KYMR (-286.52M). KYMR has more cash in the bank: 506M vs. TBPH (330M). TBPH has less debt than KYMR: TBPH (44.6M) vs KYMR (84M). TBPH has higher revenues than KYMR: TBPH (80.3M) vs KYMR (43.7M).
KYMRTBPHKYMR / TBPH
Capitalization6.51B955M681%
EBITDA-286.52M53.1M-540%
Gain YTD102.138100.213102%
P/E RatioN/A33.05-
Revenue43.7M80.3M54%
Total Cash506M330M153%
Total Debt84M44.6M188%
FUNDAMENTALS RATINGS
TBPH: Fundamental Ratings
TBPH
OUTLOOK RATING
1..100
39
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
PROFIT vs RISK RATING
1..100
87
SMR RATING
1..100
56
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
88
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KYMRTBPH
RSI
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
68%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
76%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 6 days ago
84%
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 18 days ago
69%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
KYMR
Daily Signal:
Gain/Loss:
TBPH
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ASIAX28.050.25
+0.90%
Invesco Asia Pacific Equity A
CWGCX70.970.07
+0.10%
American Funds Capital World Gr&Inc C
KMDIX32.290.02
+0.06%
Keeley Gabelli Mid Cap Dividend I
SMVLX82.56N/A
N/A
Smead Value Investor
PSSPX26.87-0.02
-0.07%
Principal SmallCap S&P 600 Index R5

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with NRIX. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
-2.18%
NRIX - KYMR
65%
Loosely correlated
-0.31%
WVE - KYMR
54%
Loosely correlated
-2.63%
VERA - KYMR
52%
Loosely correlated
-3.75%
OCUL - KYMR
52%
Loosely correlated
-1.18%
GPCR - KYMR
50%
Loosely correlated
-1.94%
More

TBPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, TBPH has been loosely correlated with VYGR. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if TBPH jumps, then VYGR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TBPH
1D Price
Change %
TBPH100%
+0.59%
VYGR - TBPH
40%
Loosely correlated
+0.25%
KYMR - TBPH
40%
Loosely correlated
-2.18%
TARA - TBPH
37%
Loosely correlated
+1.09%
VERA - TBPH
36%
Loosely correlated
-3.75%
LYRA - TBPH
36%
Loosely correlated
+0.28%
More